GBIO
Price
$0.35
Change
-$0.01 (-2.78%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
24.45M
41 days until earnings call
INVA
Price
$20.39
Change
-$0.09 (-0.44%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
1.29B
34 days until earnings call
Interact to see
Advertisement

GBIO vs INVA

Header iconGBIO vs INVA Comparison
Open Charts GBIO vs INVABanner chart's image
Generation Bio
Price$0.35
Change-$0.01 (-2.78%)
Volume$5.25K
Capitalization24.45M
Innoviva
Price$20.39
Change-$0.09 (-0.44%)
Volume$34.58K
Capitalization1.29B
GBIO vs INVA Comparison Chart in %
Loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GBIO vs. INVA commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBIO is a Buy and INVA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (GBIO: $0.36 vs. INVA: $20.48)
Brand notoriety: GBIO and INVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GBIO: 114% vs. INVA: 102%
Market capitalization -- GBIO: $24.45M vs. INVA: $1.29B
GBIO [@Biotechnology] is valued at $24.45M. INVA’s [@Biotechnology] market capitalization is $1.29B. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GBIO’s FA Score shows that 0 FA rating(s) are green whileINVA’s FA Score has 1 green FA rating(s).

  • GBIO’s FA Score: 0 green, 5 red.
  • INVA’s FA Score: 1 green, 4 red.
According to our system of comparison, INVA is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GBIO’s TA Score shows that 3 TA indicator(s) are bullish while INVA’s TA Score has 5 bullish TA indicator(s).

  • GBIO’s TA Score: 3 bullish, 6 bearish.
  • INVA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, INVA is a better buy in the short-term than GBIO.

Price Growth

GBIO (@Biotechnology) experienced а +1.31% price change this week, while INVA (@Biotechnology) price change was -4.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.00%. For the same industry, the average monthly price growth was +32.55%, and the average quarterly price growth was +15.13%.

Reported Earning Dates

GBIO is expected to report earnings on Aug 06, 2025.

INVA is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+2.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INVA($1.29B) has a higher market cap than GBIO($24.4M). INVA YTD gains are higher at: 18.040 vs. GBIO (-65.594). INVA has higher annual earnings (EBITDA): 681K vs. GBIO (-69.2M). INVA has more cash in the bank: 447M vs. GBIO (158M). GBIO has less debt than INVA: GBIO (87.6M) vs INVA (451M). INVA has higher revenues than GBIO: INVA (370M) vs GBIO (24.6M).
GBIOINVAGBIO / INVA
Capitalization24.4M1.29B2%
EBITDA-69.2M681K-10,162%
Gain YTD-65.59418.040-364%
P/E RatioN/A51.97-
Revenue24.6M370M7%
Total Cash158M447M35%
Total Debt87.6M451M19%
FUNDAMENTALS RATINGS
INVA: Fundamental Ratings
INVA
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
53
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GBIOINVA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
64%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 24 days ago
85%
Bullish Trend 11 days ago
67%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 2 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
56%
View a ticker or compare two or three
Interact to see
Advertisement
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TCREX18.08N/A
N/A
Nuveen Real Estate Sec Sel A
ALSRX16.09N/A
N/A
Alger Small Cap Growth Institutional I
OWLSX21.02N/A
N/A
Old Westbury Large Cap Strategies
BRSTX13.95N/A
N/A
MFS Blended Research Small Cap Eq R3
CSUZX24.79N/A
N/A
Cohen & Steers Global Infrastructure Z

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with CCCC. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
-1.51%
CCCC - GBIO
50%
Loosely correlated
-1.28%
ATXS - GBIO
49%
Loosely correlated
-1.91%
IDYA - GBIO
48%
Loosely correlated
+1.06%
FHTX - GBIO
48%
Loosely correlated
+0.62%
IPSC - GBIO
47%
Loosely correlated
-4.74%
More

INVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, INVA has been loosely correlated with INBX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if INVA jumps, then INBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INVA
1D Price
Change %
INVA100%
-0.97%
INBX - INVA
38%
Loosely correlated
+1.02%
SCPH - INVA
37%
Loosely correlated
+0.25%
CLDX - INVA
37%
Loosely correlated
-0.88%
GBIO - INVA
37%
Loosely correlated
-1.51%
KALV - INVA
36%
Loosely correlated
-0.17%
More